Suppr超能文献

志贺氏菌菌株对甲氧苄啶和磺胺甲恶唑的体外敏感性。

In vitro susceptibility of Shigella strains to trimethoprim and sulfamethoxazole.

作者信息

Rudoy R C, Nelson J D, Haltalin K C

出版信息

Antimicrob Agents Chemother. 1974 May;5(5):439-43. doi: 10.1128/AAC.5.5.439.

Abstract

Trimethoprim and sulfamethoxazole were tested alone and in combination against 227 recently isolated Shigella strains. Variations in medium constituents and inoculum size were used to determine the optimal testing conditions. The plate dilution method with addition of 5% lysed horse blood to the susceptibility test medium and an inoculum size of 10(2) organisms was found to provide satisfactory results. All 227 strains were inhibited by low concentrations of trimethoprim, and all were susceptible to the combination of 0.06 mug of trimethoprim per ml and 1.25 mug of sulfamethoxazole per ml. Sixteen percent of these strains were resistant to ampicillin, 33% to tetracycline, 15% to chloramphenicol, and 27% to cephalothin. Based on these in vitro observations, trimethoprim and sulfamethoxazole appear worth evaluating for treatment of shigellosis due to multiply antibiotic-resistant strains.

摘要

对甲氧苄啶和磺胺甲恶唑单独及联合应用于227株近期分离出的志贺氏菌菌株进行了测试。通过改变培养基成分和接种量来确定最佳测试条件。发现在药敏试验培养基中添加5%裂解马血并接种量为10(2)个生物体的平板稀释法能提供满意结果。所有227株菌株均被低浓度的对甲氧苄啶抑制,并且对每毫升含0.06微克对甲氧苄啶和1.25微克磺胺甲恶唑的联合制剂均敏感。这些菌株中16%对氨苄西林耐药,33%对四环素耐药,15%对氯霉素耐药,27%对头孢菌素耐药。基于这些体外观察结果,对甲氧苄啶和磺胺甲恶唑似乎值得评估用于治疗多重耐药菌株所致的志贺氏菌病。

相似文献

本文引用的文献

5
Trimethoprim, a sulphonamide potentiator.甲氧苄啶,一种磺胺增效剂。
Br J Pharmacol Chemother. 1968 May;33(1):72-90. doi: 10.1111/j.1476-5381.1968.tb00475.x.
8
Trimethoprim-sulphamethoxazole in enteric infections.甲氧苄啶-磺胺甲恶唑用于肠道感染
Scand J Infect Dis. 1972;4(3):231-40. doi: 10.3109/inf.1972.4.issue-3.10.
9
Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.甲氧苄啶-磺胺甲恶唑:体外微生物学方面
J Infect Dis. 1973 Nov;128:Suppl:442-62 p. doi: 10.1093/infdis/128.supplement_3.s442.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验